The Asia Pacific antibiotics market is expected to reach US$ 15,784.01 millionby2027 from US$ 11,591.97 millionin 2019. The market is estimated to grow with a CAGR of 4.2% from 2020 to 2027.
The growth of the market is driven by factors such as prevalence of infectious diseases and consolidated government initiatives in emerging economies in the Asia Pacific region. However, tedious and expensive process of antibiotic development and the COVID-19 pandemic are likely to restrain the Asia Pacific Antibiotics market growth to a certain extent.
Antibiotics refer to a class of medicines containing substances that are active against bacteria. These medicines either kill the bacteria or control the infection by inhibiting the bacterial reproduction, which in turn helps patient to recover. Antibiotics are specific to the type of bacteria being treated and are not able to be interchanged from one infection to another.
Due to increasing antimicrobial resistance and bacterial infection, there has been rise in efficient and integrated government programs to combat the threat, one of the strategies is One Health approach which provides a coordinated, collaborative, multidisciplinary and cross-sectoral approach in the development of health strategies for people, animals, and the environment. Another boost to the antibiotics market will be the National Health Protection Scheme under Ayushman Bharat, launched in September 2018. Pharma Vision 2020 by the government’s Department of Pharmaceuticals aims to make India a major hub for end-to-end drug discovery which will majorly drive the market in Asia Pacific. India came up with its National Action Plan on Antimicrobial Resistance (2017-21) in April 2017.
Nevertheless, India’s generics market has immense potential for growth. Indian pharmaceutical companies received record 300 generic drug approvals in USA during 2017. Thus, the above factors are likely to drive the growth of antibiotic market duringthe forecast period.
Considering the geographic and economic operations between Asian countries and China, the countries are expected to witness challenge of COVID-19. Domestic startups backed by international funding have already started witnessing back out from investors putting the development of the products in jeopardy. Additionally, the shift from antibiotics clinical trials to COVID-19trails is expected to have negative impact on the introduction of new antibiotics in the market. Such events are potentially projected to have negative impact on growth of antibiotics market in the region.
Rest of Asia PacificAntibiotics Market Revenue and Forecasts to 2027 (US$Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFICANTIBIOTICS MARKET SEGMENTATION
By Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
By Country
- China
- Japan
- India
- South Korea
- Australia
Companies Mentioned
- GlaxoSmithKline plc
- Sanofi
- Novartis AG
- Astellas Pharma Inc
- Pfizer Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Drug Class, Action Mechanism, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Antibiotics Market – By Drug Class
1.3.2 Asia Pacific Antibiotics Market – By Action Mechanism
1.3.3 Asia Pacific Antibiotics Market – By Country
2. Asia Pacific Antibiotics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Antibiotics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Antibiotics Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Antibiotics Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Bacterial Infections
5.1.2 Consolidated Government Approach in Emerging Economies
5.2 Key Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Growing Investments to Combat Antimicrobial Resistance
5.4 Future Trends
5.4.1 Incorporation of Novel Computing Technologies for Antibiotics Discovery
5.5 Impact analysis
6. Antibiotics Market – Asia Pacific Analysis
6.1 Asia Pacific Antibiotics Market Revenue Forecasts and Analysis
7. Asia Pacific Antibiotics Market Analysis And Forecasts To 2027 – By Drug Class
7.1 Overview
7.2 Asia Pacific Antibiotics market, By Drug Class 2019 & 2027 (%)
7.2.1 Asia Pacific Antibiotics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)
7.3 Sulfonamides
7.3.1 Overview
7.3.2 Asia Pacific Sulfonamides Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Aminoglycosides
7.4.1 Overview
7.4.2 Asia Pacific Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Carbapenem
7.5.1 Overview
7.5.2 Asia Pacific Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Macrolides
7.6.1 Overview
7.6.2 Asia Pacific Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Fluoroquinolones
7.7.1 Overview
7.7.2 Asia Pacific Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Penicillin
7.8.1 Overview
7.8.2 Asia Pacific Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
7.9 Cephalosporins
7.9.1 Overview
7.9.2 Asia Pacific Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
7.10 Others
7.10.1 Overview
7.10.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Asia Pacific Antibiotics Market Analysis – By Action Mechanism
8.1 Overview
8.2 Asia Pacific Antibiotics Market, By Action Mechanism 2019-2027 (%)
8.2.1 Asia Pacific Antibiotics Market Revenue and Forecasts to 2027, By Action Mechanism (US$ Mn)
8.3 Mycolic Acid Inhibitors
8.3.1 Overview
8.3.2 Asia Pacific Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 RNA Synthesis Inhibitors
8.4.1 Overview
8.4.2 Asia Pacific RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 DNA Synthesis Inhibitors
8.5.1 Overview
8.5.2 Asia Pacific DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Protein Synthesis Inhibitors
8.6.1 Overview
8.6.2 Asia Pacific Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Cell Wall Synthesis Inhibitors
8.7.1 Overview
8.7.2 Asia Pacific Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Antibiotics Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 Asia Pacific Antibiotics Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 Asia Pacific: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia Pacific: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.4 Asia Pacific: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.5 Asia Pacific: Antibiotics Market, by Country, 2018 & 2027 (%)
9.1.6 China: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 China: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 China: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.6.3 China: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.7 Japan: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Japan: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Japan: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.7.3 Japan: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.8 India: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 India: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 India: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.8.3 India: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.9 South Korea: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 South Korea: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 South Korea: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.9.3 South Korea: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.10 Australia: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Australia: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Australia: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.10.3 Australia: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
10. Impact Of COVID-19 Pandemic on Asia Pacific Antibiotics Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 GlaxoSmithKline plc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sanofi
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Novartis AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Astellas Pharma Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Antibiotics Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)
Table 2. Asia Pacific Antibiotics Market Revenue and Forecasts To 2027, By Action Mechanism (US$ Mn)
Table 3. Asia Pacific Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 5. China Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 6. China Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 8. Japan Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 9. India Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 10. India Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 11. South Korea Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 12. South Korea Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 13. Australia Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 14. Australia Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 15. Glossary of Terms, Antibiotics Market
LIST OF FIGURES
Figure 1. Antibiotics Market Segmentation
Figure 2. Asia Pacific Antibiotics Market Overview
Figure 3. Cephalosporin Segment Held Largest Share of Product in Antibiotics Market
Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Antibiotics Market - Leading Country Markets (US$ Mn)
Figure 6. Antibiotics Market - Asia Pacific PEST Analysis
Figure 7. Antibiotics market impact analysis of driver and restraints
Figure 8. Asia Pacific Antibiotics market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Asia Pacific Antibiotics market, By Drug Class 2019 & 2027 (%)
Figure 10. Asia Pacific Sulfonamides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Antibiotics Market, by Action Mechanism 2019 & 2027 (%)
Figure 19. Asia Pacific Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia Pacific Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Asia Pacific Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Asia Pacific: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. Asia Pacific Antibiotics Market Revenue and Forecast to 2027 (USD Million)
Figure 27. China: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Japan: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. India: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. South Korea: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Australia: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of Covid-19 Pandemic in Asia-Pacific Country Markets
The List of Companies - Asia Pacific Antibiotics Market
- GlaxoSmithKline plc
- Sanofi
- Novartis AG
- Astellas Pharma Inc
- Pfizer Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Antibiotics Market
Jun 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)